CN1762493A - Process for preparing compound aminophylline tablet - Google Patents
Process for preparing compound aminophylline tablet Download PDFInfo
- Publication number
- CN1762493A CN1762493A CN 200410067287 CN200410067287A CN1762493A CN 1762493 A CN1762493 A CN 1762493A CN 200410067287 CN200410067287 CN 200410067287 CN 200410067287 A CN200410067287 A CN 200410067287A CN 1762493 A CN1762493 A CN 1762493A
- Authority
- CN
- China
- Prior art keywords
- aminophylline
- acid
- tablet
- compound
- filler
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a process for preparing compound aminophylline tablet, wherein the compound aminophylline tablet prepared through the process has good stability, thus is suitable for mass production.
Description
Technical field:
The invention belongs to technical field of medicine.Be specifically related to a kind of preparation method of compound aminophylline tablet.
Background technology:
The aminophylline bronchial smooth muscle that can relax, effect is more obvious when bronchial smooth muscle is in spasticity.Aminophylline oral absorbs better, is distributed in body tissue after the absorption, can see through blood brain barrier.Be used for the treatment of bronchial asthma, cardiac edema and cardiac asthma etc. clinically.The also normal and other drug compound recipes such as chlorphenamine maleate, theophylline, Bisolvon, ephedrine hydrochloride, clenbuterol hydrochloride and phenobarbital of aminophylline are used for the treatment of bronchial asthma, asthmatic bronchitis, allergic asthma and mixed asthma etc.
Aminophylline reveals to be put in air, because of absorbing carbon dioxide is gradually separated out theophylline; Aminophylline easily decomposites the part ethylenediamine after heating and moisture absorption.After aminophylline and some medicines were made compound tablet, there were many problems in the quality of its storage period, the easy yellowing of slice, thin piece or form mottle; Sometimes also can cause slice, thin piece to expand and fragmentation.
Summary of the invention:
Technical problem to be solved by this invention is to overcome above-mentioned defective, a kind of preparation method that improves the preparation process technology of research design, the quality stability when guaranteeing its storage.
The invention provides a kind of preparation method of compound aminophylline tablet, this method be with pulverize or sieve after mixing granulations such as aminophylline, other drug composition and regulator, filler, binding agent, disintegrating agent, additive, with fluidizer, lubricant, disintegrating agent mixing, compacting in flakes again.Also can further pack film-coat.
The method of mixing granulation described in the method for the present invention can adopt conventional wet granulation, rapid mixing to granulate and fluidized-bed spray granulation, also can adopt the dried method that extrudes grain.The drying of wet granular can be with oven drying or fluid bed drying.
Prepare aminophylline compound medicament composition tablet with the present invention, aminophylline is to become 100% composition by following proportioning with other drug composition and pharmaceutical carrier.
| (component) aminophylline other drug composition conditioning agent filler adhesive disintegrant additive glidant lubricant film clothing material plasticizer colouring agent | ? 20～70％ 0.5～50％ 0.1～10％ 5～70％ 0.2～30％ 1～10％ 0.05～15％ 0～2％ 0.2～5％ 0～10％ 0～2％ 0～1％ |
Other drug composition described in the preparation method of the present invention is chlorphenamine maleate, theophylline, Bisolvon, ephedrine hydrochloride or clenbuterol hydrochloride etc.
Used pharmaceutical carrier has regulator, filler, binding agent, disintegrating agent, additive, fluidizer, lubricant, film clothing material, plasticizer, coloring agent etc. in the inventive method.
Above-mentioned regulator can be organic acid such as citric acid, tartaric acid, malic acid, fumaric acid, maleic acid, lactic acid; Also can be mineral acids such as phosphoric acid, carbonic acid.The most frequently used is citric acid and tartaric acid.
Above-mentioned filler can be starch, lactose, calcium hydrogen phosphate, pregelatinized Starch or calcium carbonate; Binding agent is starch slurry, simple syrup or hypromellose; Disintegrating agent is starch or carboxymethylstach sodium; Additive is sodium lauryl sulphate, poloxamer, sodium dihydrogen phosphate, sodium sulfite, sodium pyrosulfite, methionine; Fluidizer is a colloidal silica; Lubricant is magnesium stearate, stearic acid, Pulvis Talci or Polyethylene Glycol; Film clothing material is hypromellose, all kinds of acrylic resin, ethyl cellulose or methylcellulose, also can use the premix material of book film coating; Plasticizer is Polyethylene Glycol, propylene glycol, Oleum Ricini or phthalic acid diethyl ester.
Compound aminophylline tablet good stability with the inventive method preparation, through the accelerated test result of Detection of Stability show in 40 ℃, relative humidity 75% environment, place 6 months after, the appearance luster of slice, thin piece still is a white, and it is stable that content keeps, and average dissolution all＞90%.The sealing storage is after 12 months in the room temperature high-density polyethylene bottle, and the appearance luster of slice, thin piece still is a white, and it is stable that content keeps, and average dissolution all＞90%.The correlation analysis method of testing:
The aminophylline assay is referring to the content assaying method under Chinese Pharmacopoeia version aminophylline in 2000 the sheet item; The aminophylline dissolution test is referring to the inspection method under Chinese Pharmacopoeia version aminophylline in 2000 the sheet item.
Stability data
1, accelerated test data
Sample packaging: tablet is packed into and is sealed in the high-density polyethylene bottle, places in 40 ℃, relative humidity 75% environment.
Example 1 sample
Example 2 samples
Example 4 samples
2, room temperature storage data
Sample packaging: tablet is packed into and is sealed in the high-density polyethylene bottle, and room temperature is placed.
Example 1 sample
Example 2 samples
Example 4 samples
3, appearance luster comparative test data
With the compound aminophylline sheet of the inventive method preparation, with the tablet of prior art for preparing do after the accelerated test appearance luster relatively, the result is as follows:
Sample packaging: tablet is packed into and is sealed in the high-density polyethylene bottle, places 6 months in 40 ℃, relative humidity 75% environment.
Show that from above-mentioned test method of the present invention is used to prepare compound aminophylline tablet good practical value is arranged, method of the present invention is easy, is suitable for the scale suitability for industrialized production.
The specific embodiment:
Example 1 compound aminophylline sheet (aminophylline, chlorphenamine maleate)
| (component) aminophylline chlorphenamine maleate starch phosphate hydrogen calcium pregelatinized starch citric acid sodium hydrogensulfite | (pharmaceutical compositions) (other drug composition) (filler, disintegrating agent) (filler) (filler) (regulator) (additive) | (mg/ sheet) 70 2 50 10 40 2 0.5 |
| 10% starch slurry magnesium stearate white Opadry water, ethanol | (binding agent) (lubricant) (coating premix material) (solvent) | An amount of 1.5 about 4 is an amount of |
Operational approach:
By above-mentioned prescription with aminophylline, Bisolvon respectively pulverizing sieve, then with filler, disintegrating agent and the regulator, the additive mix homogeneously that sieve and handle through pulverizing, the starch slurry of adding 10% is made soft material in blender, soft material is made wet grain on wobbler, put in the baking oven dry, even with mix lubricant again, be pressed into label.Label packs Film coated tablets with Opadry.
Example 2 compound aminophylline sheets (aminophylline, Bisolvon, chlorphenamine maleate)
| (component) aminophylline bromhexine hydrochloride chlorphenamine maleate starch pregelatinized starch lauryl sodium sulfate tartaric acid 10% starch slurry dolomol | (pharmaceutical compositions) (other drug composition) (other drug composition) (filler, disintegrant) (filler) (additive) (conditioning agent) (adhesive) (lubricant) | (mg/ sheet) 75 15 1.5 65 40 0.25 2.5 an amount of 1.5 |
Operational approach:
By above-mentioned prescription with aminophylline, Bisolvon and chlorphenamine maleate respectively pulverizing sieve, then with filler, disintegrating agent and the regulator, the additive mix homogeneously that sieve and handle through pulverizing, the starch slurry of adding 10% is made soft material in blender, soft material is made wet grain on wobbler, in fluidized drier after the drying, even with mix lubricant, compacting in flakes.
Example 3 compound aminophylline sheets (aminophylline, ephedrine hydrochloride)
| (component) aminophylline ephedrine hydrochloride starch pregelatinized Starch citric acid | (pharmaceutical compositions) (other drug composition) (filler, disintegrating agent) (filler) (regulator) | (mg/ sheet) 100 15 60 35 2 |
| Lauryl sodium sulfate sodium dihydrogen phosphate 10% starch slurry dolomol colloidal silica acrylic acid IV resin castor-oil plant profit, ethanol | (additive) (additive) (adhesive) (lubricant) (glidant) (film clothing material) (plasticizer) (solvent) | 0.2 2 an amount of 1.5 0.3 about 5 about 0.2 is an amount of |
Operational approach:
By above-mentioned prescription with aminophylline, ephedrine hydrochloride respectively pulverizing sieve, then with filler, disintegrating agent and the regulator, the additive mix homogeneously that sieve and handle through pulverizing, the starch slurry of adding 10% is made soft material in blender, soft material is made wet grain on wobbler, put in the baking oven dry, with lubricant, fluidizer mix homogeneously, be pressed into tablet again.Label packs Film coated tablets with acrylic acid IV resin.
Example 4 compound aminophylline sheets (aminophylline, Bisolvon)
| (component) aminophylline bromhexine hydrochloride starch phosphate hydrogen calcium pregelatinized starch tartaric acid sodium hydrogensulfite Hydroxypropyl methylcellulose water, ethanol dolomol | (pharmaceutical compositions) (other drug composition) (filler, disintegrant) (filler) (filler) (conditioning agent) (additive) (adhesive) (solvent) (lubricant) | (mg/ sheet) 100 15 50 10 40 3 0.5 1.25 an amount of 1.5 |
Operational approach:
By above-mentioned prescription with aminophylline and Bisolvon respectively pulverizing sieve; then with filler, disintegrating agent mix homogeneously; regulator, additive and hypromellose are dissolved in and are mixed with liquid adhesive in the Diluted Alcohol; join in the above-mentioned compound; making granule in the mixer granulator fast; after the drying, even with mix lubricant again in fluidized drier, be pressed into tablet.
Claims (4)
1, a kind of preparation method of compound aminophylline tablet, it is characterized in that this method is mixing granulations such as the aminophylline after will pulverizing or sieve and other drug composition and regulator, filler, binding agent, disintegrating agent, additive, with fluidizer, lubricant, disintegrating agent mixing, compacting packs film-coat in flakes or further again; Prepare aminophylline compound medicament composition tablet with the present invention, aminophylline is to become 100% composition by following proportioning with other drug composition and pharmaceutical carrier:
Component
Aminophylline 20～70%
Other drug composition 0.5～50%
Regulator 0.1～10%
Filler 5～70%
Binding agent 0.2～30%
Disintegrating agent 1～10%
Additive 0.05～15%
Fluidizer 0～2%
Lubricant 0.2～5%
Film clothing material 0～10%
Plasticizer 0～2%
Coloring agent 0～1%.
2, press the preparation method of the described a kind of compound aminophylline tablet of claim 1, the method that it is characterized in that wherein said mixing granulation is granulated and fluidized-bed spray granulation for adopting conventional wet granulation, rapid mixing, also can adopt the dried method that extrudes grain, the drying of wet granular can be with oven drying or fluid bed drying.
3, by the preparation method of the described a kind of compound aminophylline tablet of claim 1, it is characterized in that wherein said other drug composition is chlorphenamine maleate, Bisolvon, ephedrine hydrochloride or clenbuterol hydrochloride.
4, press the preparation method of the described a kind of compound aminophylline tablet of claim 1, it is characterized in that wherein said regulator is organic acid such as citric acid, tartaric acid, malic acid, fumaric acid, maleic acid, lactic acid, also can be mineral acids such as phosphoric acid, carbonic acid, the most frequently used is citric acid and tartaric acid; Filler is starch, lactose, calcium hydrogen phosphate, pregelatinized Starch or calcium carbonate; Binding agent is starch slurry, simple syrup or hypromellose; Disintegrating agent is starch or carboxymethylstach sodium; Additive is sodium lauryl sulphate, poloxamer, sodium dihydrogen phosphate, sodium sulfite, sodium pyrosulfite, methionine; Fluidizer is a colloidal silica; Lubricant is magnesium stearate, stearic acid, Pulvis Talci or Polyethylene Glycol; Film clothing material is hypromellose, all kinds of acrylic resin, ethyl cellulose or methylcellulose, also can use the premix material of book film coating; Plasticizer is Polyethylene Glycol, propylene glycol, Oleum Ricini or phthalic acid diethyl ester.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100672876A CN100453116C (en) | 2004-10-19 | 2004-10-19 | Process for preparing compound aminophylline tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100672876A CN100453116C (en) | 2004-10-19 | 2004-10-19 | Process for preparing compound aminophylline tablet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1762493A true CN1762493A (en) | 2006-04-26 |
| CN100453116C CN100453116C (en) | 2009-01-21 |
Family
ID=36746950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100672876A Active CN100453116C (en) | 2004-10-19 | 2004-10-19 | Process for preparing compound aminophylline tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100453116C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102188445A (en) * | 2010-03-12 | 2011-09-21 | 上海延安药业有限公司 | Compound preparation of aminophylline, and preparation method thereof |
| CN102440992A (en) * | 2011-12-19 | 2012-05-09 | 岳阳新华达制药有限公司 | Bambutero hydrochloride and doxofylline-contained compound preparation and preparation method thereof |
| CN103877052A (en) * | 2014-03-27 | 2014-06-25 | 哈药集团制药总厂 | Aminophylline tablet and preparation method thereof |
| CN106511363A (en) * | 2016-12-07 | 2017-03-22 | 郑州仁宏医药科技有限公司 | Western medicine composition for treating bronchitis and preparation method of western medicine composition |
| CN106727641A (en) * | 2016-12-07 | 2017-05-31 | 郑州仁宏医药科技有限公司 | It is a kind of to treat medicine of bronchitis and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
| CN1042492C (en) * | 1991-10-31 | 1999-03-17 | 东北制药总厂 | Preparing method for apovincamine acid ethyl ester |
| CN1137409A (en) * | 1996-05-10 | 1996-12-11 | 郑枢邦 | Medicine for treatment of cough and asthma |
| CN1186017C (en) * | 2001-10-09 | 2005-01-26 | 陈立民 | Process for preparing medicine to prevent and cure diabetes, hyperlipomia and obesity |
-
2004
- 2004-10-19 CN CNB2004100672876A patent/CN100453116C/en active Active
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102188445A (en) * | 2010-03-12 | 2011-09-21 | 上海延安药业有限公司 | Compound preparation of aminophylline, and preparation method thereof |
| CN102188445B (en) * | 2010-03-12 | 2012-10-31 | 上海延安药业有限公司 | Compound preparation of aminophylline, and preparation method thereof |
| CN102440992A (en) * | 2011-12-19 | 2012-05-09 | 岳阳新华达制药有限公司 | Bambutero hydrochloride and doxofylline-contained compound preparation and preparation method thereof |
| CN103877052A (en) * | 2014-03-27 | 2014-06-25 | 哈药集团制药总厂 | Aminophylline tablet and preparation method thereof |
| CN106511363A (en) * | 2016-12-07 | 2017-03-22 | 郑州仁宏医药科技有限公司 | Western medicine composition for treating bronchitis and preparation method of western medicine composition |
| CN106727641A (en) * | 2016-12-07 | 2017-05-31 | 郑州仁宏医药科技有限公司 | It is a kind of to treat medicine of bronchitis and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100453116C (en) | 2009-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101836978B (en) | Solid preparation containing single crystal form | |
| CN1137684C (en) | Pharmaceutical composition stablilized with basic agent | |
| EP0487774B1 (en) | A direct tabletting auxiliary | |
| CN1197387A (en) | Pharmaceutical compsns. of conjugated estrogens and methods for their use | |
| EP3981399A1 (en) | Oral solid tablet comprising bruton's tyrosine kinase inhibitor and preparation method therefor | |
| CN1969849A (en) | Stable pharmaceutical composition containing pitavastatin calcium and preparation process thereof | |
| CN1395560A (en) | Glyburide composition | |
| CN1668284A (en) | Sustained release oral dosage forms of gabapentin | |
| CN1762493A (en) | Process for preparing compound aminophylline tablet | |
| CN1658862A (en) | Process for producing granules containing branched amino acids | |
| CN103142525A (en) | Olanzapine gastric soluble tablets and preparation method thereof | |
| JP2006176496A (en) | Solid agent and process for producing the same | |
| CN113116840B (en) | Preparation method of hydroxychloroquine sulfate tablet | |
| CN104940204A (en) | Ticagrelor solid preparation and preparation method thereof | |
| CN112336691B (en) | Ritonavir tablet and preparation method thereof | |
| CN113456639B (en) | Anti-arrhythmia pharmaceutical composition and preparation method thereof | |
| CN1739575A (en) | Solid and liquid attapulgite prepn for treating digestive tract diseases | |
| CN104666263B (en) | A kind of tablet containing Levetiracetam and preparation method thereof | |
| CN103127108A (en) | Telmisartan amlodipine tablet, and preparation method and use thereof | |
| CN1241568C (en) | Compound paracetamol and chlorphenamine maleate slow releasing tablet and its preparation | |
| CN1314400C (en) | Solid preparation taken through oral cavity of compound MEthoxyphEnaminE and preparation method | |
| CN104644587A (en) | Preparation method of medicine composition for treating cardiovascular disease | |
| WO2007143959A2 (en) | Tablet containing metformin | |
| CN1600313A (en) | Cefetamet pivoxil hydrochloride dispersion dispersion tablets and preparation method | |
| US20040126422A1 (en) | Novel co-processing method for oral drug delivery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 201823, Shanghai, Jiading District outer Pine Road No. 446 Patentee after: Shanghai Chinese Medicine Pharmaceutical Co. Ltd. Address before: 201823, Shanghai, Jiading District outer Pine Road No. 446 Patentee before: Shanghai Zhongxi Pharmaceutical Co., Ltd. |